PubMed Health⌕ Search

Biomedical subjects

J Didier

Publications and source records attributed to J Didier.

36 records · Page 2Linked to original sources
PubMed1981

Prospective study of Epstein Barr virus (EBV) infection during pregnancy.

The serological EBV profile of 2752 pregnant women characterized in most cases a latent EBV carrier state. The pregnancy rarely reactived this latent infection. But mothers with an "active" EBV serology gave birth more frequently than others to still born or defective bodies. In six pregnancies with primary EBV infection, detected early, four presented a pathological delivery. Furthermore the follow up of the EBV profile in 719 mothers revealed a significant relation between defective births and persistent EA antibodies. The role of EBV has yet to be precisely defined but the early detection of anti-EA EBV antibodies should be considered as a risk indicator in the management of pregnancy.

Antibodies, Viral↗
PubMed1980

[Epstein-Barr virus infections in pregnancy. The serological profile of active infections in pregnant women. Their possible relationship with perinatal mortality (author's transl)].

A significant number of cases of deaths and of perinatal misfortunes are still of unknown origin. The role of pathological infection is probably important in these cases and particularly those in the Torch group of viruses, and among these, as has been shown by epidemiological and virological tests, the Epstein-Barr virus (E.B.V.). The authors have undertaken a prospective study based on serology, looking for E.B.V. antibodies in pregnancy. 1,164 women were studied and 74 of these had perinatal abnormalities. There is a significant relationship between active E.B.V. infection and mishaps in pregnancy.

Abortion, Spontaneous↗
PubMedDate not supplied

Characterization of a 75-kDa Epstein-Barr virus capsid protein using a new monoclonal antibody H250.

A monoclonal antibody (mAb) designated H250, directed against an Epstein-Barr virus (EBV) capsid antigen, was obtained following immunization of BALB/c mice with naked particles from the producer cell line B95.8. This antigen was present in the producer lines B95.8, P3HR1, M81, RI and CA, and absent from the non-producer lines BJAB, Raji and 1022. H250 did not inhibit the transformation of cord blood lymphocytes by the B95.8 virus, nor did it inhibit EA induction on Raji cells by the P3HR1 virus. In addition, H250 showed no fluorescence on living B95.8 cells. This indicates that H250 does not recognize a membrane antigen. By indirect immunofluorescence, no fluorescence was observed on induced Raji cells or on PAA-treated B95.8 cells. Thus, H250 recognized a late antigen of the EBV virus replication cycle. Agglutination of naked virus by H250 showed it was directed against a capsid antigen. Positive fluorescence was observed on cells treated with tunicamycin, indicating that H250 recognized a protein. The molecular weight of this protein was obtained by Western blot and was approximately 75 kDa. The blocking tests carried out with H250 seemed to indicate that this Ab appeared late in patient sera during primary infection.

Agglutination Tests↗
PubMedDate not supplied

The Epstein-Barr virus (EBV) in human pathology. II. Serologic profiles of EBV infections.

Antibodies to EBV induced intracellular antigens, (VCA, EA, NA) and VCA-IgM antibodies have been investigated to define EBV serologic profile of 245 individuals. This profile was a first studied in EBV primary infections. In infectious mononucleosis, the efficiency of EBV serodiagnosis is lower than Paul Bunnel Davidsohn reaction (PBD) : primary infection profile is only characterised in 80% of the positive PBD infectious mononucleosis (IM). On the other hand, EBV antibodies are preponderant for diagnosis in other clinical manifestations of EBV primary-infection were PBD is not alwasy positive (47%). EBV antibodies of patients with various diseases and antibodies of normal subjects show different profiles. By interpretation of these profiles one discuss the possibility to characterize reinfection, and either latent or active persistant infection.

Antibodies, Viral↗